Literature DB >> 17614756

STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses.

Hongwei Gao1, Peter A Ward.   

Abstract

The expanding knowledge involving the cytokine transcription factor network has provided new insights into the acute lung inflammatory response. There are numerous lung inflammatory diseases that at present lack effective treatment (adult respiratory distress syndrome, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, asthma and so on). Although cytokines themselves and their receptors comprise a communication system that is crucial to detect the presence of pathogens and the injured lung, the cytokine signals and the milieu that surrounds these signals can clearly determine the nature of the lung responses that are elicited. Functioning as a transcription factor, STAT3 participates in the signaling pathways for many cytokines in various cells and organs that are regulated by the suppressor of cytokine signaling (SOCS) family, including SOCS3. Recently, data on the activation and function of STAT3 and SOCS3 in the lung during the acute inflammatory response are emerging, suggesting that these molecules can be potential targets for regulating pulmonary inflammatory responses. The authors review the progress in understanding how STAT3 and SOCS3 regulate the lung inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614756     DOI: 10.1517/14728222.11.7.869

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  35 in total

1.  Mycobacterium tuberculosis serine protease Rv3668c can manipulate the host-pathogen interaction via Erk-NF-κB axis-mediated cytokine differential expression.

Authors:  Quanju Zhao; Wu Li; Tian Chen; Ying He; Wanyan Deng; Hongping Luo; Jianping Xie
Journal:  J Interferon Cytokine Res       Date:  2014-03-31       Impact factor: 2.607

2.  Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs.

Authors:  Steffen Kunzmann; Jennifer J P Collins; Yang Yang; Stefan Uhlig; Suhar G Kallapur; Christian P Speer; Alan H Jobe; Boris W Kramer
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

3.  The Saguenay-Lac-Saint-Jean asthma familial collection: the genetics of asthma in a young founder population.

Authors:  C Laprise
Journal:  Genes Immun       Date:  2014-03-20       Impact factor: 2.676

Review 4.  Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.

Authors:  Tara V Saco; Mason T Breitzig; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-03       Impact factor: 6.914

5.  Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response.

Authors:  Yanjie Zhang; Liya Zhang; Jinhong Wu; Caixia Di; Zhenwei Xia
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

6.  Large-scale analysis of network bistability for human cancers.

Authors:  Tetsuya Shiraishi; Shinako Matsuyama; Hiroaki Kitano
Journal:  PLoS Comput Biol       Date:  2010-07-08       Impact factor: 4.475

Review 7.  Genetics of asthma susceptibility and severity.

Authors:  Rebecca E Slager; Gregory A Hawkins; Xingnan Li; Dirkje S Postma; Deborah A Meyers; Eugene R Bleecker
Journal:  Clin Chest Med       Date:  2012-07-07       Impact factor: 2.878

8.  MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.

Authors:  Kripa Patel; Anita Kollory; Asami Takashima; Sibaji Sarkar; Douglas V Faller; Sajal K Ghosh
Journal:  Cancer Lett       Date:  2014-01-31       Impact factor: 8.679

9.  Effects of lipopolysaccharide, multiwalled carbon nantoubes, and the combination on lung alveolar epithelial cells.

Authors:  M Pacurari; I May; P B Tchounwou
Journal:  Environ Toxicol       Date:  2016-02-16       Impact factor: 4.119

10.  Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice.

Authors:  Jiahua Yu; Xiaopeng Yuan; Yang Liu; Kaishuo Zhang; Jie Wang; Haowen Zhang; Fenju Liu
Journal:  Lung       Date:  2015-11-13       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.